ContraFect Corporation Announces First Quarter 2015 Results
May 15, 2015 07:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - May 15, 2015) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
ContraFect Corporation Announces Commencement of Phase 1 Clinical Trial of CF-301 for Staph Bloodstream Infections, Including MRSA
April 29, 2015 07:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Apr 29, 2015) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
ContraFect Corporation Announces Fourth Quarter and Full Year 2014 Results
April 06, 2015 07:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Apr 6, 2015) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
ContraFect to Present at 27th Annual ROTH Conference
March 03, 2015 07:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Mar 3, 2015) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
ContraFect to Present at 17th Annual BIO CEO & Investor Conference
February 03, 2015 07:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Feb 3, 2015) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
ContraFect to Present Company Overview, Including Clinical Plan for CF-301, at the 7th Annual Biotech Showcase
January 07, 2015 07:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Jan 7, 2015) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
ContraFect Receives FDA Approval to Initiate Clinical Trials of CF-301 for MRSA Bloodstream Infections
December 22, 2014 07:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Dec 22, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
ContraFect Corporation to Present at the Oppenheimer 25th Annual Healthcare Conference
December 04, 2014 07:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Dec 4, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
ContraFect Submits Complete Response to IND Clinical Hold for CF-301
December 02, 2014 07:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Dec 2, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
ContraFect Corporation Announces Third Quarter 2014 Results
November 14, 2014 17:38 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Nov 14, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...